Categories: MarketsNews

Duopharma stock rises as EPF increases stake

by BERNAMA / graphic by MZUKRI

DUOPHARMA Biotech stock price has seen a steady rise since July amid vaccine optimism and it is expected to continue its upward momentum as the Employees Provident Fund (EPF) has increased its holdings.

An analyst said retail investors usually would mirror the movement of institutional investors which would be on a “buy low sell high” trend.

“The two top pharmaceutical companies in Malaysia, namely Pharmaniaga, which is owned by the Armed Forces Fund Board (LTAT), and Duopharma would be the biggest gainers once the COVID-19 vaccine is available.

“Hence, the prospects for ‘buy’ is maintained for the long run,” she said.

In terms of stake, Duopharma’s majority shareholder Bumiputera Investment Foundation holds 46.5 per cent, EPF (7.82 per cent) and Permodalan Nasional Bhd (4.94 per cent).

As at 10.26pm, Duopharma stock rose five sen to RM3.38 with 1.94 million shares traded.


Recent Posts

Malaysia Airlines commences gradual reinstatement of flights to and from Sabah, Sarawak and Labuan

MALAYSIA Airlines has commenced the gradual reinstatement of flights to and from Sabah, Sarawak and…

1 min ago

Bursa Malaysia higher in early trade as investors focus on stocks with high cash reserves

BURSA Malaysia started the morning trading in positive territory, attributed to broad-based buying in response…

8 mins ago

Ringgit opens easier against US dollar

The ringgit opened easier against the US dollar today as the greenback strengthened further following…

18 mins ago

Ascott Malaysia’s bold takeover reveals Fox Glenmarie as premier destination

by AKMAR ANNUAR ASCOTT Malaysia, a subsidiary of CapitaLand Investment Ltd, has made a significant…

24 mins ago

Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization

SEOUL, South Korea, April 18, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bioscience (CEO…

31 mins ago

Brewer’s Spent Yeast Market Projected to Reach $2.17 billion by 2030 – Exclusive Report by 360iResearch

PUNE, India, April 18, 2024 /PRNewswire/ -- The report titled "Brewer's Spent Yeast Market by…

40 mins ago